FDA.reportPublic FDA data

deflazacort 22.75 MG/ML Oral Suspension [Emflaza]

RxCUI
1870968
RxNorm name
deflazacort 22.75 MG/ML Oral Suspension [Emflaza]
Display name
deflazacort 22.75 MG/ML Oral Suspension [Emflaza]
Full name
deflazacort 22.75 MG/ML Oral Suspension [Emflaza]
Term type
SBD
Status
DailyMed mapping
Updated
2026-06-04 23:38:52

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
EMFLAZADEFLAZACORTPTC Therapeutics, Inc.31b347d2-f156-4055-9d8f-7cf0df4202962025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 1870968

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
31b347d2-f156-4055-9d8f-7cf0df420296Emflaza 22.75 MG/mL Oral Suspension [PSN] · deflazacort 22.75 MG/ML Oral Suspension [Emflaza] [SBD] · Emflaza 22.75 MG/ML Oral Suspension [SY]321These highlights do not include all the information needed to use EMFLAZA ® safely and effectively. See full prescribing information for EMFLAZA. EMFLAZA ® (deflazacort) tablets, for oral use EMFLAZA ® (deflazacort) oral suspension Initial U.S. Approval: 201720251113